Hopp til innhold
Close

Get alerts of updates about «Paternal obesity-associated DNA methylation: an investigation into its reproducibility, reversibility and association with fetal growth restriction, an antecedent to adult obesity and type-2 diabetes.»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Paternal obesity-associated DNA methylation: an investigation into its reproducibility, reversibility and association with fetal growth restriction, an antecedent to adult obesity and type-2 diabetes.

Oops, something went wrong...

... contact nettredaksjon@fhi.no.

... reload the page and try again-

Project

Paternal obesity-associated DNA methylation: an investigation into its reproducibility, reversibility and association with fetal growth restriction, an antecedent to adult obesity and type-2 diabetes. - project description

Published Updated

Our aim is to generate a robust ‘obesity-associated’ DNA methylation profile and validation of genomic regions.


Summary

Around the world, the prevalence of obesity is increasing relentlessly. Once obesity is acquired, weight loss is difficult to achieve and in particular to maintain. Furthermore, the prevalence of obesity in children and young adults is also increasing and more strongly associated with obesity-related morbidities than in older populations. The origins of obesity are first evident in utero, as the fetal response to parental nutritional status. Studies in animals have shown how acquired parental obesity can be transmitted across generations via epigenetic mechanisms through either maternal or paternal gametes. Human studies to investigate whether similar epigenetic mechanisms associated with periconception paternal obesity and insulin resistance might also influence fetal growth are of great scientific interest. Our aim is to generate a robust ‘obesity-associated’ DNA methylation profile (DMP) and validation of genomic regions selected from previous studies of adult obesity, insulin resistance, metabolic syndromes, and fetal growth retardation. We will do this by examining the epigenetic pattern in peripheral blood samples from men either above 30 in BMI or below 25. If we find differences we will extend the data analyses to full trios (mother, father and child).

 

See the full project description at Cristin for more information about results, researchers, contact information etc.

Project participants

Project leader

Per Magnus, Norwegian Institute of Public Health

Project participants

Ronny Myhre, Norwegian Institute of Public Health
Astanand Jugessur, Norwegian Institute of Public Health
Rob Lowe, Queen Mary University of London
Michelle Holland, Queen Mary University of London
Fredrika Asenius, University College London Hospitals

Start

01.03.2017

End

31.12.2022

Status

Active

Approvals

Regional committees for medical and health research ethics

Project owner/ Project manager

Norwegian Institute of Public Health

Project manager

Per Minor Magnus

Participant at FHI

Astanand Jugessur